Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Ying Zhao

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|February 12, 2024
O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiencyFu-Ying Zhao, Xue Chen, Jia-Mei Wang, et al.
Basic Research in Cardiology|January 22, 2026
Cardiac lymphatics: functional plasticity in development, disease, and precision-targeted therapiesLiang Hao, Bai-Qiang Li, Fu-Ying Zhao, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 9, 2024
Regulation of AUF1 alternative splicing by hnRNPA1 and SRSF2 modulate the sensitivity of ovarian cancer cells to cisplatinJia-Mei Wang, Ning Liu, Xue-Jing Wei, et al.
Molecular Medicine Reports|April 21, 2021
lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axisKun Fang, Zheng-Jie Xu, Su-Xiao Jiang, et al.
Cell Death & Disease|March 18, 2025
TFE3 and HIF1α regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cellsSi-Qi Wang, Ning Liu, Qi Zhang, et al.
Molecular Medicine Reports|February 14, 2025
[Retracted] lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axisKun Fang, Zheng-Jie Xu, Su-Xiao Jiang, et al.
Molecular Cancer|October 2, 2025
Decoding the ubiquitin network: molecular mechanisms and therapeutic vulnerabilities for precision radio-sensitization in cancerFu-Ying Zhao, Li-Ye Shi, Lu-Jiao Yu, et al.
Iscience|April 17, 2026
Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDACYan-Jie Liu, Fu-Ying Zhao, Jia-Mei Wang, et al.
Pharmacological Research|May 18, 2026
Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: The Systemic Execution Hub of MetastasisLiang Hao, Shi-Yang Lu, Fu-Ying Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2022
Development of precocious puberty in children: Surmised medicinal plant treatmentXiao-Xu Han, Fu-Ying Zhao, Kan-Ru Gu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cellular Oncology (Dordrecht, Netherlands)|February 12, 2024
O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiencyFu-Ying Zhao, Xue Chen, Jia-Mei Wang, et al.
Basic Research in Cardiology|January 22, 2026
Cardiac lymphatics: functional plasticity in development, disease, and precision-targeted therapiesLiang Hao, Bai-Qiang Li, Fu-Ying Zhao, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 9, 2024
Regulation of AUF1 alternative splicing by hnRNPA1 and SRSF2 modulate the sensitivity of ovarian cancer cells to cisplatinJia-Mei Wang, Ning Liu, Xue-Jing Wei, et al.
Molecular Medicine Reports|April 21, 2021
lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axisKun Fang, Zheng-Jie Xu, Su-Xiao Jiang, et al.
Cell Death & Disease|March 18, 2025
TFE3 and HIF1α regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cellsSi-Qi Wang, Ning Liu, Qi Zhang, et al.
Molecular Medicine Reports|February 14, 2025
[Retracted] lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axisKun Fang, Zheng-Jie Xu, Su-Xiao Jiang, et al.
Molecular Cancer|October 2, 2025
Decoding the ubiquitin network: molecular mechanisms and therapeutic vulnerabilities for precision radio-sensitization in cancerFu-Ying Zhao, Li-Ye Shi, Lu-Jiao Yu, et al.
Iscience|April 17, 2026
Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDACYan-Jie Liu, Fu-Ying Zhao, Jia-Mei Wang, et al.
Pharmacological Research|May 18, 2026
Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: The Systemic Execution Hub of MetastasisLiang Hao, Shi-Yang Lu, Fu-Ying Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 22, 2022
Development of precocious puberty in children: Surmised medicinal plant treatmentXiao-Xu Han, Fu-Ying Zhao, Kan-Ru Gu, et al.
Pageof 3